| Clara Maass Medical Center | |
| One Clara Maass Drive, Belleville, New Jersey 07109 | |
| (973) 450-2963 | |
| Name | Clara Maass Medical Center |
|---|---|
| Location | One Clara Maass Drive, Belleville, New Jersey |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 20 |
| Occupancy Rate | 49% |
| Medicare ID (CCN) | 315505 |
| Legal Business Name | Clara Maass Medical Center |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1386766244 |
| Organization Name | CLARA MAASS MEDICAL CENTER |
| Doing Business As | CLARA MAASS CONTINUING CARE CENTER AT BELLEVILLE |
| Address | 1 Clara Maass Dr, Belleville, NJ 07109 |
| Phone Number | 973-450-2908 |
News Archive
It is estimated that between 5% and 10% of breast and ovarian cancers are familial in origin, which is to say that these tumours are attributable to inherited mutations from the parents in genes such as BRCA1 or BRCA2.
Aperio Technologies, Inc. announced today that the United States Patent and Trademark Office has issued the company patent No. 7,428,324 entitled "System and Method for Data Management in a Linear-array based Microscope Slide Scanner."
Biogen Idec announced today it has received conditional approval from the European Commission for FAMPYRA® (prolonged-release fampridine tablets) to improve walking in adult patients with multiple sclerosis who have walking disability.
Belén Merck Navarro, Medicine professor at Valencia and Castellón's CEU UCH university is the only Spaniard among the 17 surgeons from 11 different countries that specialize in breast cancer who took part in a clinical trial on the usefulness of 3D images to evaluate the aesthetic results of conservative surgery in breast cancer
› Verified 8 days ago
| NPI Number | 1679507685 |
| Organization Name | CLARA MAASS MEDICAL CENTER |
| Doing Business As | CLARA MAASS CONTINUING CARE CENTER & BELLEVILLE |
| Address | 1 Clara Maass Dr, Belleville, NJ 07109 |
| Phone Number | 973-450-2908 |
News Archive
It is estimated that between 5% and 10% of breast and ovarian cancers are familial in origin, which is to say that these tumours are attributable to inherited mutations from the parents in genes such as BRCA1 or BRCA2.
Aperio Technologies, Inc. announced today that the United States Patent and Trademark Office has issued the company patent No. 7,428,324 entitled "System and Method for Data Management in a Linear-array based Microscope Slide Scanner."
Biogen Idec announced today it has received conditional approval from the European Commission for FAMPYRA® (prolonged-release fampridine tablets) to improve walking in adult patients with multiple sclerosis who have walking disability.
Belén Merck Navarro, Medicine professor at Valencia and Castellón's CEU UCH university is the only Spaniard among the 17 surgeons from 11 different countries that specialize in breast cancer who took part in a clinical trial on the usefulness of 3D images to evaluate the aesthetic results of conservative surgery in breast cancer
› Verified 8 days ago
| NPI Number | 1861629156 |
| Organization Name | CLARA MAASS MEDICAL CENTER |
| Doing Business As | CLARA MAASS MEDICAL CENTER TRANSITIONAL CARE UNIT |
| Address | 1 Clara Maass Dr, Belleville, NJ 07109 |
| Phone Number | 973-450-2008 |
News Archive
It is estimated that between 5% and 10% of breast and ovarian cancers are familial in origin, which is to say that these tumours are attributable to inherited mutations from the parents in genes such as BRCA1 or BRCA2.
Aperio Technologies, Inc. announced today that the United States Patent and Trademark Office has issued the company patent No. 7,428,324 entitled "System and Method for Data Management in a Linear-array based Microscope Slide Scanner."
Biogen Idec announced today it has received conditional approval from the European Commission for FAMPYRA® (prolonged-release fampridine tablets) to improve walking in adult patients with multiple sclerosis who have walking disability.
Belén Merck Navarro, Medicine professor at Valencia and Castellón's CEU UCH university is the only Spaniard among the 17 surgeons from 11 different countries that specialize in breast cancer who took part in a clinical trial on the usefulness of 3D images to evaluate the aesthetic results of conservative surgery in breast cancer
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
It is estimated that between 5% and 10% of breast and ovarian cancers are familial in origin, which is to say that these tumours are attributable to inherited mutations from the parents in genes such as BRCA1 or BRCA2.
Aperio Technologies, Inc. announced today that the United States Patent and Trademark Office has issued the company patent No. 7,428,324 entitled "System and Method for Data Management in a Linear-array based Microscope Slide Scanner."
Biogen Idec announced today it has received conditional approval from the European Commission for FAMPYRA® (prolonged-release fampridine tablets) to improve walking in adult patients with multiple sclerosis who have walking disability.
Belén Merck Navarro, Medicine professor at Valencia and Castellón's CEU UCH university is the only Spaniard among the 17 surgeons from 11 different countries that specialize in breast cancer who took part in a clinical trial on the usefulness of 3D images to evaluate the aesthetic results of conservative surgery in breast cancer
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|